When an electronic record system also provides an AI assistant, independent suppliers need to demonstrate what they add beyond the customer's existing software. Native access to records and familiar workflows may be an advantage, but does not prove superior performance. Buyers should compare the complete task, the available deployment and their ability to change course.
Strategic analysis, 14 September 2026. Announced pilots and product ambitions are not treated as universally available functionality. The evaluation and procurement questions below are proposals, not findings from a live comparison.
Epic is not standing outside the assistant market
In an 18 August 2026 announcement, Epic described Ochsner's initial Ergo Visit use. The report says four family and internal medicine clinicians began on 3 August. It describes visit preparation, source-linked chart information and native Chart with Art functionality drafting documentation and orders for clinician review.
That is a concrete example of an electronic record vendor extending into the assistant workflow. It is also a bounded early deployment report. It does not show that every Epic customer has the same feature enabled, or that the experience has already demonstrated comparative clinical benefit.
Tandem's 14 September 2026 announcement describes a different starting position: an assistant expanding towards clinic-wide operations. The strategic pressure therefore runs in both directions. Independent AI companies can broaden their role, while established record-system vendors can add assistance within their own products.
Native access is an opportunity, not an outcome
A product inside the record system may have a convenient route to information the clinician already needs. It may also reduce separate logins or avoid transferring material between applications. These are possible advantages to test, not universal properties of every native implementation.
The decisive question is what happens in the actual workflow. Can the user inspect the source of a summary? Does the draft distinguish historical information from the current encounter? Is it clear whether an order is proposed, approved or completed? A familiar interface does not make those distinctions unnecessary.
Equally, a separate assistant should not be dismissed because it opens elsewhere. It could offer a better experience for a specialist task or work across systems a clinician encounters in different settings. Such advantages must be demonstrated rather than inferred from independence.
The relevant comparison is between supported implementations, not between the abstract ideas of "native" and "third party".
The baseline has changed
Imagine a fictional hospital department that originally evaluated a separate assistant because its record system offered no comparable function. At renewal, the record vendor introduces a native option. The department should reconsider the baseline rather than repeat the old business case unchanged.
The new question is not whether AI can produce a note. It is what additional value the separate supplier provides relative to the native option actually available to that department, after local costs and constraints are considered.
The separate product may still justify its place through a better reviewed output, a more useful specialty workflow, stronger cross-system support or more responsive implementation. Alternatively, the native option may adequately meet the requirement and remove an unnecessary additional purchase.
Neither outcome follows automatically from the vendor's size. The department needs a comparison using representative tasks, current versions and the same definition of completion.
Ask each supplier to follow the same synthetic encounter
A practical test can begin with an original, fictional record containing a previous diagnosis, a superseded plan and an unresolved investigation. The encounter then introduces a patient correction to the history and a proposed follow-up action. This is educational test material, not a real patient case.
Ask each product to support the task within its documented capabilities. Where one implementation cannot access a particular source or perform a particular action, record that limitation instead of quietly supplying extra data and calling the comparison equivalent.
Review the output at each transition. Did the summary preserve chronology? Was the patient's correction retained? Can the reviewer find the source for a statement? Is an intended action distinguishable from a completed one? What happens when the task is interrupted before saving?
Count the work until the clinician and relevant service staff can see that the required task is complete. A fast draft followed by uncertain filing is not directly comparable with a slower generation step that reaches an intelligible endpoint.
No such head-to-head test was performed for this article. Publishing invented timings or accuracy scores would obscure the implementation differences the exercise is designed to reveal.
Established vendors can compete and collaborate
A record-system vendor need not choose exclusively between building its own AI and supporting external products. Different customers may need different capabilities, and an outside supplier may address a task the native product does not handle adequately.
The same company can therefore be an integration partner in one workflow and a competitor in another. That is a strategic possibility, not a claim about the terms of a particular Epic contract.
For established vendors, a sensible response would make native functionality easier to assess while giving customers clear information about supported third-party options. A customer should be able to distinguish a technical integration, a locally enabled workflow and a future plan.
For independent suppliers, the corresponding task is to make their additional value specific. "More advanced AI" is not enough. A buyer needs to see what the product completes, who can use it and why that difference matters in the service.
Portability belongs in the evaluation, not only the exit discussion
A buyer should ask what remains usable when a supplier changes. That is not an allegation that any company discussed here prevents export. It is a practical procurement question for both native and independent systems.
Start with the outputs. Can the service retain its final records in the required location? Can reviewers distinguish a draft from an approved version? Where a source link or review history is important, what survives outside the original interface?
Then consider configuration. Templates, approved local material and workflow preferences may require effort to reproduce elsewhere. Establishing what can be exported or documented helps the buyer estimate the cost of change without assuming it is impossible.
Finally, examine how an interrupted transition would be handled. Who supports access to the existing record, what happens to unfinished tasks and how is successful transfer confirmed? These are questions for a supplier discussion and local technical assessment, not a universal legal checklist.
Contractual flexibility matters, but so does practical flexibility. A nominal ability to leave may be less useful if nobody has tested whether the required information can be retained in a usable form.
Do not use breadth to conceal an unresolved requirement
A platform may demonstrate preparation, documentation, orders and communications in a single session. The buyer should still evaluate each consequential handover. A polished overall journey cannot compensate for uncertainty about a required approval or the state of the final record.
Conversely, a narrower supplier should not treat focus as an automatic quality claim. It needs to show where the focused experience is better for the intended task and where another product is still required.
The purchasing decision can then be made in stages. Establish minimum requirements first, test completion and review second, and compare convenience and cost only among options that meet the essential conditions. That avoids a scoring exercise in which numerous attractive extras outweigh a fundamental mismatch.
A professional learning environment serves another continuity need
This article is published by iatroX and includes its learning tools as a separate category. The September 2026 simulation description includes shared progress across the web and native apps. Its CPD documentation, checked on 14 September, describes retained access to completed learning evidence after a subscription ends.
Those features address the continuity of professional learning, not the storage of an organisation's patient record. A clinician may value keeping revision and learning activity consistent across training stages or workplaces without expecting that environment to replace an employer's clinical software.
There is no claim that Epic or another record system prevents such learning continuity. The distinction simply helps buyers avoid treating every clinician-facing function as part of the same procurement.
The verdict depends on the existing system and the unmet task
For an organisation whose available native assistant meets its requirements, a separate subscription needs a clear additional justification. For one working across several systems or needing a specialist capability, an independent supplier may remain preferable if it demonstrates the relevant advantage.
For an individual clinician seeking professional learning rather than operational automation, neither enterprise roadmap settles the choice. The appropriate tool is the one that supports the learning task and preserves a useful record of it.
The record system becoming an assistant does not end competition. It changes the question competitors must answer: what can the customer accomplish with you that they cannot accomplish as well with what they already have?
Frequently asked questions
Does Epic already offer native AI-assisted charting?
Epic's August 2026 Ergo Visit announcement describes native Chart with Art functionality at an initial Ochsner deployment. It should not be read as confirmation that every Epic customer has the same functionality enabled.
Does native integration prove better clinical performance?
No. Access and convenience should be assessed separately from output quality, source support, review requirements and successful completion of the task.
What should buyers establish before replacing an independent assistant?
Confirm the functionality actually available locally, compare representative workflows and test what happens to records, configurations and unfinished work. A roadmap or demonstration alone is not a replacement plan.